Device
Tenex
Tenex is a medical device with 3 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
100%(1 trials)
Phase Distribution
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Completed(1)
Detailed Status
Recruiting2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
completed133%
recruiting267%
Recent Activity
2 active trials
Showing 3 of 3
recruitingnot_applicable
Evaluation of TENEX for Greater Trochanteric Pain Syndrome (GTPS)
NCT05710627
recruiting
Randomized Controlled Trial (RCT) of Open Debridement Versus Tenex
NCT05757739
completednot_applicable
Percutaneous Interruption of the Coracohumeral Ligament for the Treatment of Frozen Shoulder
NCT04549051
Clinical Trials (3)
Showing 3 of 3 trials
NCT05710627Not Applicable
Evaluation of TENEX for Greater Trochanteric Pain Syndrome (GTPS)
NCT05757739
Randomized Controlled Trial (RCT) of Open Debridement Versus Tenex
NCT04549051Not Applicable
Percutaneous Interruption of the Coracohumeral Ligament for the Treatment of Frozen Shoulder
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3